David J. Sanger
#161,802
Most Influential Person Now
David J. Sanger's AcademicInfluence.com Rankings
David J. Sangerpsychology Degrees
Psychology
#3631
World Rank
#4085
Historical Rank
Behavioral Neuroscience
#48
World Rank
#50
Historical Rank
David J. Sangerbiology Degrees
Biology
#12864
World Rank
#16368
Historical Rank
Neuroscience
#2191
World Rank
#2252
Historical Rank
Download Badge
Psychology Biology
David J. Sanger's Degrees
- Bachelors Psychology University of California, Berkeley
Similar Degrees You Can Earn
Why Is David J. Sanger Influential?
(Suggest an Edit or Addition)David J. Sanger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice (2000) (399)
- Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. (1986) (276)
- Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. (1997) (234)
- Rate-dependent effects of drugs: A review of the literature (1976) (219)
- Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents Comparison with diazepam and buspirone (1998) (195)
- Risk Assessment Behaviour: Evaluation of Utility in the Study of 5-HT-Related Drugs in the Rat Elevated Plus-Maze Test (1997) (192)
- Endorphinergic mechanisms in the control of food and water intake (1981) (179)
- The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents (2004) (150)
- Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies (2000) (147)
- Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes (1994) (145)
- Amisulpride: from animal pharmacology to therapeutic action (1997) (132)
- Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice (1999) (128)
- A Comparative Study of the Effects of Selective and Non-Selective 5-HT2 Receptor Subtype Antagonists in Rat and Mouse Models of Anxiety (1997) (126)
- Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. (1992) (115)
- Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. (1996) (105)
- Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists (1999) (105)
- Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide. (1985) (104)
- Orphanin FQ, a novel neuropeptide with anti-stress-like activity (1999) (101)
- Contemporary Research in Behavioral Pharmacology (1978) (97)
- Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. (1990) (96)
- Pharmacological studies on synthetic flavonoids: comparison with diazepam (1999) (93)
- The effects of compounds varying in selectivity as 5-HT1A receptor antagonists in three rat models of anxiety (2000) (90)
- Behavioral Effects of Acute and Chronic Fluoxetine in Wistar–Kyoto Rats (1999) (88)
- New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (ω) receptor subtypes (1999) (82)
- Quantitative motor assessment in FALS mice: a longitudinal study (1997) (79)
- Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice (1997) (77)
- GABA and the behavioral effects of anxiolytic drugs. (1985) (73)
- Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity (1997) (72)
- The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure (1987) (70)
- Pharmacological and behavioral profile of alpidem as an anxiolytic. (1990) (69)
- Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats. (1989) (68)
- Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice (1992) (66)
- The effects of opiate antagonists on food intake are stereospecific (1981) (66)
- Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. (2000) (65)
- The effects of clozapine on shuttle-box avoidance responding in rats: Comparisons with haloperidol and chlordiazepoxide (1985) (60)
- Differential effects of morphine on food and water intake in food deprived and freely-feeding rats (2004) (59)
- Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT1A receptor antagonists (1999) (58)
- Genetic differences in the mouse defense test battery (1997) (57)
- Preferential involvement of D3 versus D2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self-administration in rats (1998) (56)
- Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine–oxidase activity and monoamine levels (1998) (54)
- The Pharmacology and Mechanism of Action of Zolpidem. (1998) (53)
- Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine (1996) (49)
- Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors (1992) (48)
- The pharmacology and abuse potential of buprenorphine: A new antagonist analgesic. (1983) (48)
- The effects of fluoxetine and zimeldine on the behavior of olfactory bulbectomized rats (1986) (47)
- Investigation of the development of tolerance to the actions of zolpidem and midazolam (1987) (47)
- 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. (1999) (47)
- An analysis of the effects of systemically administered clonidine on the food and water intake of rats (1983) (46)
- The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands (1996) (46)
- Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls (2004) (46)
- Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats. (1995) (46)
- CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours (1997) (45)
- Further behavioural evidence for the selective sedative action of zolpidem (1988) (43)
- Effects of D1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity (1999) (43)
- Pharmacological and molecular targets in the search for novel antipsychotics (2000) (42)
- Further evidence for differences between non-selective and BZ-1 (ω1) Selective, benzodiazepine receptor ligands in murine models of “state” and “trait” Anxiety (1996) (42)
- The actions of SCH 23390, a D1 receptor antagonist, on operant and avoidance behavior in rats (1987) (42)
- Increased food and water intake produced in rats by opiate receptor agonists (2004) (40)
- Mild traumatic lesion of the right parietal cortex of the rat: Selective behavioural deficits in the absence of neurological impairment (1998) (39)
- Effects of Drugs on Schedule-Controlled Behavior (1987) (39)
- Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain (1997) (39)
- Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands. (1999) (37)
- A comparison of the effects of opiate antagonists on operant and ingestive behavior (1982) (37)
- Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex. (1999) (37)
- Effects of buspirone and related compounds on suppressed operant responding in rats. (1990) (36)
- The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task. (1999) (36)
- Mild traumatic lesion of the right parietal cortex in the rat: Characterisation of a conditioned freezing deficit and its reversal by dizocilpine (1998) (36)
- DTG-induced circling behaviour in rats may involve the interaction between σ sites and nigro-striatal dopaminergic pathways (1995) (36)
- Differential effects of chlordiazepoxide and d-amphetamine on responding maintained by a DRL schedule of reinforcement (2004) (34)
- Rate-dependent effects of drugs on the variable-interval behavior of rats. (1975) (34)
- The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic (2004) (33)
- Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296 (1987) (31)
- Investigation of the actions of the benzodiazepine antagonists Ro 15-1788 and CGS 8216 using the schedule-controlled behavior of rats (1986) (30)
- Anxiolytic drugs and the acquisition of conditioned fear in mice (2004) (30)
- The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands. (1996) (30)
- The effects of new hypnotic drugs in rats trained to discriminate ethanol (1997) (30)
- Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effects in rats. (1992) (30)
- Discriminative Stimulus Effects of Drugs Acting at GABAA Receptors Differential Profiles and Receptor Selectivity (1999) (30)
- Conditioned taste aversions induced by phencyclidine and other antagonists of N-methyl-d-aspartate (1989) (30)
- The effects of tranquillizing drugs on timing behaviour in rats (1975) (28)
- Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors (1997) (28)
- Evidence for a role for dopamine D3 receptors in the effects of dopamine agonists on operant behaviour in rats. (1996) (28)
- Effects of diazepam and ripazepam on two measures of adjunctive drinking in rats (1976) (28)
- Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs (1997) (28)
- Endorphinergic Mechanisms in Food, Salt and Water Intake: An Overview (1984) (28)
- Rate-Dependence and the Effects of Benzodiazepines1 (1981) (27)
- Lithium and α-methyl-p-tyrosine prevent “manic” activity in rodents (1974) (27)
- Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. (1994) (27)
- Response decrement patterns after neuroleptic and non-neuroleptic drugs (2004) (27)
- Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol (1999) (26)
- Social competition in rats: a test sensitive to acutely administered anxiolytics (1991) (26)
- NMDA antagonists disrupt timing behaviour in rats (1992) (26)
- Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile. (1987) (26)
- Schedule-induced drinking and thirst: A pharmacological analysis (1979) (26)
- Animal Models of Anxiety and the Screening and Development of Novel Anxiolytic Drugs (1991) (26)
- The effects of pimozide and of reward omission on fixed-interval behavior of rats maintained by food and electrical brain stimulation (1981) (25)
- Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice (2004) (25)
- Performance of a passive avoidance response is disrupted by compounds acting at 5HT1A receptors (1989) (25)
- Animal models of anxiety and the development of novel anxiolytic drugs (1991) (25)
- Schedule-induced drinking of chlordiazepoxide solutions by rats (1977) (25)
- The Effects of Drugs on Adjunctive Behavior (1978) (24)
- Operant Behavior and the Effects of Centrally Acting Drugs (1989) (24)
- The anorectic properties of opiate antagonists (1984) (23)
- Increased rates of punished responding produced by buspirone-like compounds in rats. (1992) (23)
- Nicotine and schedule-induced drinking in rats (1978) (23)
- The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists (1989) (23)
- The effects of NMDA antagonists on punished exploration in mice (1991) (23)
- Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-d-aspartate receptors? (2006) (20)
- The Effects of Chlordiazepoxide on the Development of Adjunctive Drinking in Rats (1975) (20)
- Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride. (1997) (20)
- Neuroprotective effect of eliprodil: attenuation of a conditioned freezing deficit induced by traumatic injury of the right parietal cortex in the rat. (1998) (20)
- Reduction of Oral Ethanol Self-Administration in Rats by Monoamine Oxidase Inhibitors (1999) (19)
- Discriminative stimulus properties of anxiolytic and sedative drugs: pharmacological specificity. (1988) (19)
- Learned taste aversion to saccharin produced by orally consumed d-amphetamine (1980) (19)
- Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence (1993) (19)
- Differences in Anxiolytic-Like Profile of Two Novel Nonbenzodiazepine BZ (ϖ) Receptor Agonists on Defensive Behaviors of Mice (1999) (19)
- The search for novel antipsychotics: pharmacological and molecular targets (2004) (18)
- Substitution by NMDA antagonists and other drugs in rats trained to discriminate ethanol (1993) (18)
- Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents. (1974) (18)
- Behavioural effects of the α2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine (2004) (17)
- Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice (2005) (17)
- Intragastric water and the acquisition of schedule-induced drinking. (1976) (16)
- Effects of d-Amphetamine and of β-phenylethylamine on fixed interval responding maintained by self-regulated lateral hypothalamic stimulation in rats (1985) (16)
- Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors (2005) (16)
- The interaction between zolpidem and beta-CMC: a clue to the identification of receptor sites involved in the sedative effect of zolpidem. (1988) (16)
- Buspirone, gepirone and ipsapirone disrupt both active and passive avoidance responding in rats (1989) (15)
- Psychopharmacological strategies in the search for cognition enhancers. (1990) (14)
- Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9 10 of the cerebellum: A D3 receptor mediated effect? (2000) (14)
- Social competition in dominant rats can be attenuated by anxiogenic drugs (1992) (14)
- Study of the modulatory activity of bz (ω) receptor ligands on defensive behaviors in mice: Evaluation of the importance of intrinsic efficacy and receptor subtype selectivity (1999) (13)
- Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system. (1993) (13)
- Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats (1995) (12)
- Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps (1994) (12)
- Ifenprodil and Eliprodil: Neuroprotective NMDA Receptor Antagonists and Calcium Channel Blockers (1997) (12)
- The α2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats (2004) (12)
- [A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]. (1990) (12)
- New perspectives for the treatment of disorders of sleep and arousal. (2007) (12)
- The effects of d-amphetamine and scopolamine on drinking induced by a multiple schedule (1978) (11)
- Effects of d-amphetamine on the behavior of pigeons maintained by a second-order schedule of reinforcement. (1975) (10)
- A Variable-Interval Punishment Procedure for Assessing Anxiolytic Effects of Drugs (1978) (10)
- The D3 Antagonist PNU-99194A Potentiates the Discriminative Cue Produced by the D3 Agonist 7-OH-DPAT (2000) (10)
- The effects of d-amphetamine on the temporal control of operant responding in rats during a preshock stimulus. (1976) (10)
- Differential neuropsychopharmacological profiles of NMDA antagonists: Ifenprodil-like, PCP-like and CPP-like compounds (1990) (10)
- The effects of caffeine on timing behaviour in rodents: Comparisons with chlordiazepoxide (2004) (9)
- The Mouse Defense Test Battery: An experimental model of different emotional states. (1999) (9)
- Chlordiazepoxide-induced hyperphagia in rats: lack of effect of GABA agonists and antagonists (2004) (9)
- Animal Models and Recent Developments in the Search for Novel Anxiolytics (1991) (9)
- Inhibition of scopolamine-induced stimulation of Y-maze activity by alpha-methyl-p-tyrosine and by lithium. (1974) (9)
- Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines (2004) (9)
- Discriminative stimulus effects of ω (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system (2005) (8)
- Behavioral pharmacology in the era of neuroscience. (1991) (8)
- Animal Models for Assessing Anxiolytic, Neuroleptic, and Antidepressant Drug Action (1988) (8)
- Scopolamine and adjunctive drinking in rats (1976) (7)
- Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644. (1997) (7)
- Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic (2005) (6)
- The behavioural pharmacology of anxiety and depression. (1997) (6)
- Discriminative stimulus properties of 8-OH-DPAT : relationship to affinity for 5 HT 1 A receptors (6)
- Schedule-Dependent Effects Of Chlordiazepoxide On Operant Behavior In Rats (1976) (6)
- The Effects of D-Amphetamine and Chlordiazepoxide on Responding Maintained by a Multiple Schedule of Food and Electrical Brain Stimulation in Rats (1981) (6)
- d-amphetamine and adjunctive drinking in rats (1977) (5)
- Subtype-selective benzodiazepine receptor ligands (2000) (5)
- The anorectic action of naloxone is attenuated by adaptation to a food-deprivation schedule (2004) (5)
- Applications of behavioural pharmacology in drug discovery. (2003) (5)
- Behavioural Pharmacology of Dopamine D2 and D3 Receptors: Use of the Knock-out Mice Approach (2002) (5)
- Effects of d-amphetamine on temporal and spatial discrimination in rats (1978) (5)
- The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats. (1988) (4)
- Effects of chronic treatment with triazolam on operant responding in rats (1994) (4)
- Behavioural Sensitization. (1993) (4)
- Anorectic actions of the opiate antagonist naloxone. (1981) (4)
- S-19-1 Novel neuroleptics acting on presynaptic dopaminergic receptors (1995) (3)
- Zimelidine does not antagonise the effects of alcohol or diazepam on the acquisition of conditioned fear in mice. (1986) (3)
- The anti‐ischaemic drug, eliprodil, blocks hyperactivity induced by intra‐accumbens injection of spermine (1995) (3)
- Editorial Announcements Behavioural Pharmacology is now listed in Current Contents. (1991) (3)
- Alpidem, an omega-1 receptor-selective partial agonist: a new approach to anxiety treatment (1991) (3)
- IMPROVEMENT OF MEMORY IN RATS BY SR 141716, A SELECTIVE ANTAGONIST AT THE CB1 CANNABINOID RECEPTOR (1996) (3)
- The effects of fenfluramine on schedule-induced drinking in rats (1979) (3)
- The benzodiazepine antagonist CGS 8216 decreases both shocked and unshocked drinking in rats (2004) (2)
- Benzodiazepine (omega) receptor partial agonists and the acquisition of conditioned fear in mice. (1995) (2)
- LACK OF TOLERANCE AND PHYSICAL DEPENDENCE AFTER TREATMENT WITH ALPIDEM, A NEW IMIDAZOPYRIDINE ANXIOLYTIC, IN MICE (1992) (2)
- New advances in the understanding and treatment of addiction. (2002) (2)
- Benzodiazepine (ω) receptor partial agonists and the acquisition of conditioned fear in mice (1995) (2)
- DRUG DISCRIMINATION AND ANXIOLYTIC DRUGS (1992) (2)
- Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan. (1989) (2)
- Effects of chlordiazepoxide on the self-regulated duration of lateral hypothalamic stimulation in rats (2004) (2)
- Fixed-Interval Responding in Mongolian Gerbils (1979) (2)
- THE EFFECTS OF NICOTINE ON SERIAL REACTION TIME PERFORMANCE IN THE RAT (1998) (2)
- The Pharmacological Properties of Tiapride (1998) (2)
- Discriminative stimulus effects of the α2-adrenoceptor antagonist idazoxan (1989) (2)
- 5HT1A Agonists, 5HT3 Antagonists and Benzodiazepines: Their Comparative Behavioural Pharmacology (1991) (2)
- Eliprodil: a novel neuroprotective agent acting at a modulatory site of the NMDA receptor (1994) (2)
- THE BEHAVIOURAL PHARMACOLOGY OF SCHIZOPHRENIA (2000) (1)
- Behavioural pharmacology of impulse control. (2009) (1)
- Ionotropic receptors and stimulus effects of drugs: whisky and water or vodka on the rocks? Commentary on Grant, "Emerging neurochemical in the action of ethanol at ligand-gated ion channels" (1994) (1)
- THE PUTATIVE DOPAMINE D3 RECEPTOR ANTAGONIST PNU 99194A POTENTIATES THE DISCRIMINATIVE STIMULUS INDUCED BYTHE DOPAMINE D3/D2 RECEPTOR AGONIST 7‐OH-DPAT (1998) (1)
- DIFFERENTIAL EFFECTS OF COMPOUNDS ACTING AT VARIOUS SITES OFTHE NMDA RECEPTOR COMPLEX ON THE PREPULSE INHIBITION OFTHE STARTLE REFLEX IN RATS (1998) (1)
- Pharmacological approaches to learning and memory. (1992) (1)
- 65-67 Amisulpride is a preferential D3 dopamine receptor antagonist (1997) (1)
- 14-114 Evaluation of the anxiolytic and anti-panic potential of befloxatone and moclobemide in mice (1997) (1)
- Aspects of Psychopharmacology (1984) (1)
- 14-86 Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice (1997) (0)
- Pharmacological profile of SL 85.0274, a novel imidazopyridine anxiotytic (1990) (0)
- Keynote lecture 5 : phychopharmacological strategies in the search for cognition enhancers (1990) (0)
- New for 1992... (1992) (0)
- Effects of chlordiazepoxide, ripazepam and d-amphetamine on conditioned acceleration of timing behaviour in rats (1976) (0)
- Announcement of 2007 Special Issue: The Behavioural Pharmacology of the Hippocampus (2006) (0)
- Editorial???Behavioural Pharmacology of Cannabinoids (2005) (0)
- DISCRIMINATIVE STIMULUS EFFECTS OF DRUGS ACTING AT GABAA RECEPTORS: DIFFERENTIAL PROFILES, RECEPTOR SELECTIVITY AND RELEVANCETO ABUSE POTENTIAL (1998) (0)
- Human behavioural pharmacology. (1998) (0)
- P.4.002 Comparative studies of different nicotinic agonists in spatial or sequential memory models in aged rats (1997) (0)
- 12-4 The role of the D3 dopamine receptor subtype in behaviour (1997) (0)
- EFFICACY OF D1 DOPAMINE RECEPTOR AGONISTS TO REDUCE ORAL ETHANOL SELF‐ADMINISTRATION IN RATS (1998) (0)
- THE PSYCHOPHARMACOLOGY OF THE POLYAMINE SITE (1995) (0)
- The pharmacology and mechanisms of action of atypical antipsychotic drugs: dopamine and beyond (2006) (0)
- GABAB Receptors and Antidepressant Drugs (1989) (0)
- Psychopharmacology of Positive and Negative Symptoms of Schizophrenia: Behavioural Models and Pharmacological Profiles (1996) (0)
- Atypical antipsychotics: similarities and differences at the synaptic level (2003) (0)
- P.5.007 Effects of D2/D3 dopamine agonists and antagonists on oral ethanol self-administration in rats (1997) (0)
- USE OF SOCIAL BEHAVIOUR AND CONDITIONED PERFORMANCE FOR EVALUATING ANXIOLYTIC DRUGS (1992) (0)
- Announcement of 2010 Special Issue Non-traditional drug targets in behavioural pharmacology (2009) (0)
- Editorial???Behavioural Aspects of Neurodegeneration and Neuroprotection (2006) (0)
- Editorial: The Behavioural Pharmacology of the Hippocampus (2007) (0)
- The behavioral pharmacology of nicotine (1999) (0)
- Behavioural Pharmacology and Stimulant Abuse. (1990) (0)
- Behavioural Pharmacology of Alcohol. (1994) (0)
- Announcement of 2009 Special Issue: Behavioural pharmacology of impulse control (2008) (0)
- 26-7 Which pharmacological properties are responsible for the clinical efficacy and good tolerability of Tiapride? (1997) (0)
- Target receptors for hypnotics: Relevance to pharmacological profile and therapeutic action (1993) (0)
- TDS: Is it a bird, is it a plane ??? ? Commentary on Antelman et al., ???Time dependent sensitization (TDS) ??? possible implications for clinical psychopharmacology??? (1997) (0)
- NEUROPSYCHOPHARMACOLOGICAL PROFILE OF LITOXETINE, A NEW SELECTIVE INHIBITOR OF SEROTONIN UPTAKE (1992) (0)
- Behavioural genetics and its relevance to psychiatry. (2008) (0)
- ALPIDEM, UNLIKE CHLORDIAZEPOXIDE, DOES NOT POTENTIATE THE SODIUM BARBITAL‐INDUCED LOSS OF RIGHTING REFLEX IN MICE. (1992) (0)
- Comparison of the behavioural profiles of non-selective and BZ-1 (??1) selective benzodiazepine receptor hypnotics in animal models of anxiety (1997) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David J. Sanger?
David J. Sanger is affiliated with the following schools:
